Free Trial
NASDAQ:PASG

Passage Bio (PASG) Stock Price, News & Analysis

Passage Bio logo
$0.40 -0.04 (-9.07%)
As of 02:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Passage Bio Stock (NASDAQ:PASG)

Key Stats

Today's Range
$0.35
$0.44
50-Day Range
$0.27
$0.50
52-Week Range
$0.26
$1.33
Volume
1.01 million shs
Average Volume
302,817 shs
Market Capitalization
$24.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.50
Consensus Rating
Buy

Company Overview

Passage Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

PASG MarketRank™: 

Passage Bio scored higher than 53% of companies evaluated by MarketBeat, and ranked 505th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Passage Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Passage Bio has only been the subject of 1 research reports in the past 90 days.

  • Read more about Passage Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Passage Bio are expected to grow in the coming year, from ($1.03) to ($0.74) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Passage Bio is -0.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Passage Bio is -0.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Passage Bio has a P/B Ratio of 0.43. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Passage Bio's valuation and earnings.
  • Percentage of Shares Shorted

    3.38% of the float of Passage Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Passage Bio has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Passage Bio has recently decreased by 1.11%, indicating that investor sentiment is improving.
  • Dividend Yield

    Passage Bio does not currently pay a dividend.

  • Dividend Growth

    Passage Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.38% of the float of Passage Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Passage Bio has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Passage Bio has recently decreased by 1.11%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Passage Bio this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for PASG on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Passage Bio insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $274,961.00 in company stock.

  • Percentage Held by Insiders

    Only 5.00% of the stock of Passage Bio is held by insiders.

  • Percentage Held by Institutions

    53.48% of the stock of Passage Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Passage Bio's insider trading history.
Receive PASG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Passage Bio and its competitors with MarketBeat's FREE daily newsletter.

PASG Stock News Headlines

Passage Bio Announces 1-for-20 Reverse Stock Split
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
PASG Passage Bio, Inc. - Seeking Alpha
See More Headlines

PASG Stock Analysis - Frequently Asked Questions

Passage Bio's stock was trading at $0.5671 at the beginning of 2025. Since then, PASG shares have decreased by 25.1% and is now trading at $0.4250.

Passage Bio, Inc. (NASDAQ:PASG) announced its earnings results on Tuesday, May, 13th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.01.

Passage Bio (PASG) raised $126 million in an initial public offering (IPO) on Friday, February 28th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Goldman Sachs and Cowen served as the underwriters for the IPO and Chardan was co-manager.

Shares of PASG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Passage Bio investors own include Enovix (ENVX), Ginkgo Bioworks (DNA), COMPASS Pathways (CMPS), Rambus (RMBS), Toast (TOST), Globant (GLOB) and Luminar Technologies (LAZR).

Company Calendar

Last Earnings
5/13/2025
Today
7/10/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PASG
CIK
1787297
Fax
N/A
Employees
130
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$4.00
Potential Upside/Downside
+1,724.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.77 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.99 per share
Price / Book
0.42

Miscellaneous

Free Float
59,041,000
Market Cap
$25.54 million
Optionable
Optionable
Beta
1.67
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PASG) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners